Related Experiment Video

Updated: Jun 20, 2026

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

Published on: April 15, 2014

Age at first dose of measles vaccination in Ethiopia

Y Berhane1, W W Schluter, F Oyewole

  • 1Addis Continental Institute of Public Health P.O. Box 26751-1000, Addis Ababa, Ethiopia.

East African Medical Journal
|August 26, 2009
PubMed

Insights

Ethiopian children receive their first measles vaccine dose at the recommended nine months of age. Strengthening routine vaccination programs is crucial for effective measles control.

Area of Science:

  • Public Health
  • Vaccinology
  • Epidemiology

Background:

  • Measles vaccination is recommended at nine months in Ethiopia and sub-Saharan Africa.
  • Data on the actual age of first measles vaccination in Ethiopia was lacking.
  • Understanding actual vaccination age is critical for preventing measles infection and epidemics.

Purpose of the Study:

  • To determine the actual age of first measles vaccination among Ethiopian children.

Main Methods:

  • Cross-sectional study design.
  • Data collected from major vaccination facilities in Addis Ababa and rural surveys.
  • Reviewed 17,674 vaccination records and surveyed 615 children (September 2004 - August 2005).

Main Results:

  • Median age for the first measles vaccine dose was nine months in both urban and rural settings.
  • Measles coverage by card and history in rural areas was 84.4%, with only 19.8% having vaccination cards.
  • A significant proportion of rural children received measles vaccination during supplemental immunization activities (SIAs) rather than routine programs.

Conclusions:

  • Current vaccination practices and coverage levels do not support delaying the first measles vaccine dose.
  • Prioritizing the strengthening of routine vaccination programs is essential.
  • Changes to the recommended age for the first measles vaccine dose should not be considered without strengthening routine services.
Abstract

More Related Videos

Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose (Herpestes Auropunctatus) Sera for Use as an Oral Rabies Vaccination Biological Marker11:28

Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose (Herpestes Auropunctatus) Sera for Use as an Oral Rabies Vaccination Biological Marker

Published on: May 31, 2019

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.